Session 19: TBI in 2026: From Big Studies to Better Prognosis and Treatment
Tracks
Hall 1
| Thursday, October 1, 2026 |
| 2:00 PM - 3:00 PM |
Details
Elham Rostami, Wilco Peul
Speakers & Chairs
Geoff Manely
Development of the CBI-M Framework for improved characterization of TBI
2:00 PM - 2:10 PM
Prof. Andrew Maas
Emeritus Professor
Antwerp University Hospital
Towards Implementation of the CBI-M Framework
2:10 PM - 2:20 PM
Prof Andras Buki
Prof.
Örebro University
Biomarkers and Modifiers in CBIM: From Insights to Implementation
2:20 PM - 2:30 PM
Dr Philipp Geiger
Resident
Medical Univeristy Innsbruck
DUAL ICP STUDY – an animal model to quantify the physiological difference in infra- and supratentorial ICP and the pathological sequelae of posterior fossa lesions
Ms Inge Van Erp
PhD-student
University Neurosurgical Center Holland
Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): a randomized, placebo-controlled, multi-center trial
Discussion
Discussion
2:55 PM - 3:00 PM
Wilco Peul
Chair
Elham Rostami
Chair
